ENTRY       D05744                      Drug
NAME        Roflumilast (JAN/USAN/INN);
            Daliresp (TN);
            Zoryve (TN)
PRODUCT     DALIRESP (AstraZeneca Pharmaceuticals LP)
            ZORYVE (Arcutis Biotherapeutics)
  GENERIC   ROFLUMILAST (Aurobindo Pharma Limited)
            ROFLUMILAST (Camber Pharmaceuticals)
            ROFLUMILAST (Micro Labs Limited)
            ROFLUMILAST (Mylan Pharmaceuticals)
            ROFLUMILAST (Novadoz Pharmaceuticals LLC)
            ROFLUMILAST (Solco Healthcare US)
            ROFLUMILAST (Strides Pharma Science Limited)
            ROFLUMILAST (Torrent Pharmaceuticals Limited)
            ROFLUMILAST (Zydus Lifesciences Limited)
            ROFLUMILAST (Zydus Pharmaceuticals USA)
FORMULA     C17H14Cl2F2N2O3
EXACT_MASS  402.035
MOL_WEIGHT  403.2075
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: R03DX07
            Product: D05744<US>
EFFICACY    Antiasthmatic, Phosphodiesterase IV inhibitor
  DISEASE   Chronic obstructive pulmonary disease [DS:H01714]
            Plaque psoriasis [DS:H01656]
TARGET      PDE4 [HSA:5141 5142 5143 5144] [KO:K13293]
  PATHWAY   hsa04024(5141+5142+5143+5144)  cAMP signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
                R03DX Other systemic drugs for obstructive airway diseases
                 R03DX07 Roflumilast
                  D05744  Roflumilast (JAN/USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Phosphodiesterase Inhibitors, Airways Disease
               Roflumilast
                D05744  Roflumilast (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D05744  Roflumilast
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D05744  Roflumilast
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE4
                 D05744  Roflumilast (JAN/USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05744
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05744
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05744
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05744
DBLINKS     CAS: 162401-32-3
            PubChem: 47207405
            ChEBI: 47657
            PDB-CCD: ROF
            LigandBox: D05744
ATOM        26
            1   C8y C    14.2100  -18.7600
            2   C8y C    14.2100  -20.1600
            3   C8x C    15.4000  -20.8600
            4   C8y C    16.6600  -20.1600
            5   C8x C    16.6600  -18.7600
            6   C8x C    15.4000  -18.0600
            7   O2a O    13.0200  -18.0600
            8   O2a O    13.0200  -20.8600
            9   C1c C    13.0200  -16.6600
            10  X   F    11.8300  -15.9600
            11  X   F    14.2100  -15.9600
            12  C1b C    11.8300  -20.1600
            13  C1y C    10.6400  -20.8600
            14  C1x C     9.2400  -20.8600
            15  C1x C     9.9400  -22.0500
            16  C5a C    17.8666  -20.8700
            17  N1b N    19.0763  -20.1847
            18  O5a O    17.8551  -22.2600
            19  C8y C    20.2966  -20.9030
            20  C8y C    20.2844  -22.3299
            21  C8x C    21.4908  -23.0402
            22  N5x N    22.7792  -22.3506
            23  C8x C    22.7213  -20.9237
            24  C8y C    21.5149  -20.2134
            25  X   Cl   21.4564  -18.8305
            26  X   Cl   19.0779  -23.0129
BOND        28
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     2   8 1
            9     7   9 1
            10    9  10 1
            11    9  11 1
            12    8  12 1
            13   12  13 1
            14   14  13 1
            15   13  15 1
            16   15  14 1
            17    4  16 1
            18   16  17 1
            19   16  18 2
            20   17  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   19  24 1
            27   24  25 1
            28   20  26 1
///
